The FDA approved fostamatinib disodium hexahydrate (Tavalisse) tablets for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia. RDR discusses with Dr James Bussel.
James Bussel, M.D.
Advertisement
Articles by James Bussel, M.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Moving the Needle in Medicine: Mentorship, Medicine, and the Making of an Innovator, With Jim Januzzi, MD
2
Inhaled Treprostinil Improves IPF Outcomes in Phase 3 TETON-1 Trial
3
What We Still Don't Know: Gaps, Phototherapy, and the Future of Pediatric Eczema Care
4
6 Gastroenterology Headlines You Missed in May 2026
5